SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : QLT PhotoTherapeutics (QLTI) -- Ignore unavailable to you. Want to Upgrade?


To: Julian who wrote (769)11/24/1999 11:48:00 AM
From: Edward W. Richmond  Read Replies (1) | Respond to of 1321
 
Julian, didn't we have problems with exclusive approval of a specific laser in Japan. Didn't the price for the device increase to the point of being prohibitive. That, I understood, was one of the reasons for problems in the use of photofrin in Japan. My memory may well not be accurate.
If this is the case, would a similar potential problem exist with Zeiss?
Regards,
Ed